VCEL Vericel Corp

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company. The Company operates in one reportable segment: the research, manufacture, and distribution of patient-specific, used in the treatment of specific diseases.

$42.11  -4.69 (-10.01%)
As of 03/03/2021 15:59:41 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
08/06/2001
45,428,794
656,940
$2,125,613,271
0.00%
SEC Edgar Online
10-Q
10-K
92346J108
US92346J1088
BSBMN89

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
742.19
15.96
17.12
2.13%
2.31%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy